Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. The company is headquartered in Abbott Park, Illinois. The Company’s principal business is the discovery, development, manufacture, and sale of a broad and diversified line of healthcare products. Its segments include Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Established Pharmaceutical Products segment is engaged in the international sales of a broad line of branded generic pharmaceutical products. Diagnostic Products segment is involved in the worldwide sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories and alternate-care testing sites. Nutritional Products segment is engaged in the worldwide sales of a broad line of adult and pediatric nutritional products. Medical Devices segment is involved in the worldwide sales of rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation and diabetes care products. The company serves people in more than 160 countries.
ABT'ün son EPS'si beklentilerle karşılaştırıldığında nasıldı?
Abbott Laboratories'in en son EPS'si $1.5 olup, $1.51 beklentilerini kazanmamak.
Abbott Laboratories ABT'ün son çeyrekteki geliri nasıl performans gösterdi?
Abbott Laboratories'in son çeyrek geliri $1.5
Abbott Laboratories'in gelir tahmini nedir?
26 Wall Street analistine göre, Abbott Laboratories'in gelir tahmini $11.74B ile $10.48B arasında değişmektedir.
Abbott Laboratories'in kazanç kalite puanı nedir?
Abbott Laboratories'in kazanç kalite puanı A-/61.57909'dir. Puan, karlılık, büyüme, nakit üretimi ve sermaye tahsisi ile kaldıraç olmak üzere dört boyuta dayanır.
Abbott Laboratories kazançlarını ne zaman rapor eder?
Abbott Laboratories'in bir sonraki kazanç raporu 2026-04-22'te bekleniyor